1. Home
  2. EXYN vs CLRB Comparison

EXYN vs CLRB Comparison

Compare EXYN & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exyn Technologies Inc. Common Stock

EXYN

Exyn Technologies Inc. Common Stock

N/A

Current Price

$2.34

Market Cap

21.2M

Sector

N/A

ML Signal

N/A

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

HOLD

Current Price

$1.91

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXYN
CLRB
Founded
N/A
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2M
24.5M
IPO Year
2026
2008

Fundamental Metrics

Financial Performance
Metric
EXYN
CLRB
Price
$2.34
$1.91
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $10.00
AVG Volume (30 Days)
★ 77.4K
54.4K
Earning Date
N/A
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$1.80
52 Week High
$6.98
$6.52

Technical Indicators

Market Signals
Indicator
EXYN
CLRB
Relative Strength Index (RSI) 37.39 25.74
Support Level $1.58 N/A
Resistance Level $2.86 $2.70
Average True Range (ATR) 0.21 0.13
MACD -0.03 -0.05
Stochastic Oscillator 9.09 14.54

Price Performance

Historical Comparison
EXYN
CLRB

About EXYN Exyn Technologies Inc. Common Stock

Exyn Technologies Inc is a pioneer in fully adaptive, cognitive mission-level autonomous robotics and artificial intelligence, delivering solutions that enable safe, efficient, and scalable autonomy in complex, GPS-denied environments. Its mission is to deliver world-class autonomous robots to data-hungry industries, unlocking new insights that drive smarter decisions. The group is leveraging proprietary Level 4B autonomy software and cutting-edge aerial and ground robotic systems. It empowers industries, including mining, construction, critical infrastructure, and defense, with real-time 3D mapping, data analytics, and autonomous navigation. Its software and hardware include ExynAI, ExynAI SDK, ExynView, Nexys, Accessories, and Platforms.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: